SCHEMBL5147111

SCHEMBL5147111

CN(CCO)c1ccc(C=O)c(O)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYBB P04839 6/20 0.49
NOX4 Q9NPH5 6/20 0.49
TYR P14679 2/20 0.44
TRIM24 O15164 2/20 0.44
TRIM33 Q9UPN9 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.38
APP P05067 1/20 0.37
EGFR P00533 1/20 0.37
ALDH1A1 P00352 3/20 0.37
MEN1 O00255 2/20 0.37
MAPT P10636 2/20 0.37
KMT2A Q03164 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
GAA P10253 1/20 0.37
THRB P10828 1/20 0.37
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
CRHBP P24387 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4515927 0.86 TYR (0.42) CYBBNOX4TYRTRIM24TRIM33
SCHEMBL11823877 0.86 TYR (0.42) CYBBNOX4TYRTRIM24TRIM33
SCHEMBL24991896 0.84 CYBB (0.39) CYBBNOX4L3MBTL1APPEGFR
SCHEMBL5729223 0.83 TYR (0.46) TYRTRIM24TRIM33L3MBTL1ALDH1A1
SCHEMBL10844181 0.83 TYR (0.47) CYBBNOX4TYRTRIM24TRIM33
SCHEMBL24991908 0.83 EGFR (0.44) CYBBNOX4L3MBTL1APPEGFR
SCHEMBL24991974 0.83 CYBB (0.38) CYBBNOX4L3MBTL1APPEGFR
SCHEMBL11740869 0.82 ALDH1A1 (0.42) CYBBNOX4TYRTRIM24TRIM33
SCHEMBL26562502 0.81 CYBB (0.40) CYBBNOX4L3MBTL1APPEGFR
SCHEMBL61553 0.81 ALDH1A1 (0.50) L3MBTL1ALDH1A1MEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1624900-A4 METHODS FOR BINDING AGENTS TO BETA-AMYLOID PLAQUES UNIV CALIFORNIA (US) 2007-05-02 EP disclosed
US-20070053831-A1 Methods for binding agents to b-amyloid plaques THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2007-03-08 US disclosed
EP-1624900-A2 METHODS FOR BINDING AGENTS TO BETA-AMYLOID PLAQUES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2006-02-15 EP disclosed
WO-2005040337-A2 METHODS FOR BINDING AGENTS TO β-AMYLOID PLAQUES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2005-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070053831-A1 Methods for binding agents to b-amyloid plaques APBA1, CLTB, FABP7 CYBB 1885/4885NOX4 3718/4885TYR 4256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.